Related references
Note: Only part of the references are listed.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Enlarged cardiophrenic lymph nodes predict disease involvement of the upper abdomen and the outcome of primary surgical debulking in advanced ovarian cancer
Anna K. Luger et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2020)
Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomised trial
Takashi Onda et al.
EUROPEAN JOURNAL OF CANCER (2020)
Exploring international differences in ovarian cancer treatment: a comparison of clinical practice guidelines and patterns of care
Charles H. Norell et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)
Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850)
Anna Fagotti et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)
Impact of residual disease on overall survival in women with Federation of Gynecology and Obstetrics stage IIIB-IIIC vs stage IV epithelial ovarian cancer after primary surgery
Sarah M. Sorensen et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2019)
Behavior of FDG-avid supradiaphragmatic lymph nodes in PET/CT throughout primary therapy in advanced serous epithelial ovarian cancer: a prospective study
Maren Laasik et al.
CANCER IMAGING (2019)
Evaluating the benefits of neoadjuvant chemotherapy for advanced epithelial ovarian cancer: a retrospective study
Yan Gao et al.
JOURNAL OF OVARIAN RESEARCH (2019)
Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials
Ignace Vergote et al.
LANCET ONCOLOGY (2018)
Factors Predicting Use of Neoadjuvant Chemotherapy Compared With Primary Debulking Surgery in Advanced Stage Ovarian CancerA National Cancer Database Study
Gary S. Leiserowitz et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)
Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase
Jacek P. Grabowski et al.
GYNECOLOGIC ONCOLOGY (2016)
Effect of neoadjuvant chemotherapy on platinum resistance in stage IIIC and IV epithelial ovarian cancer
Yanlin Luo et al.
MEDICINE (2016)
Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery and the Risk of Platinum Resistance in Epithelial Ovarian Cancer
Alexandre A. B. A. da Costa et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
Sean Kehoe et al.
LANCET (2015)
Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: A meta-analysis
Suk-Joon Chang et al.
GYNECOLOGIC ONCOLOGY (2013)
Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer
J. Alejandro Rauh-Hain et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Pleural Effusion Detected at CT prior to Primary Cytoreduction for Stage III or IV Ovarian Carcinoma: Effect on Survival
Oleg Mironov et al.
RADIOLOGY (2011)
The Danish Register of Causes of Death
Karin Helweg-Larsen
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2011)
Introduction to Danish (nationwide) registers on health and social issues: Structure, access, legislation, and archiving
Lau Caspar Thygesen et al.
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2011)
Mucinous advanced epithelial ovarian carcinoma: clinical presentation and sensitivity to platinum-paclitaxel-based chemotherapy, the GINECO experience
J. Alexandre et al.
ANNALS OF ONCOLOGY (2010)
Influence of Residual Tumor on Outcome in Ovarian Cancer Patients With FIGO Stage IV Disease
Pauline Wimberger et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
Ignace Vergote et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Role of Surgical Outcome as Prognostic Factor in Advanced Epithelial Ovarian Cancer: A Combined Exploratory Analysis of 3 Prospectively Randomized Phase 3 Multicenter Trials By the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO)
Andreas du Bois et al.
CANCER (2009)
Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: A gynecologic oncology group study
William E. Winter et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma
R Eitan et al.
CANCER (2005)
Share Paper
